| Primary |
| Apheresis |
96.7% |
| Acidosis |
3.3% |
|
| Death |
22.6% |
| Cardiac Arrest |
6.5% |
| Fall |
6.5% |
| Myocardial Infarction |
6.5% |
| Post Procedural Complication |
6.5% |
| Unresponsive To Stimuli |
6.5% |
| Cardiac Disorder |
3.2% |
| Coronary Artery Disease |
3.2% |
| Device Malfunction |
3.2% |
| Infusion Site Extravasation |
3.2% |
| Medication Error |
3.2% |
| Mesothelioma |
3.2% |
| Presyncope |
3.2% |
| Road Traffic Accident |
3.2% |
| Somnolence |
3.2% |
| Subarachnoid Haemorrhage |
3.2% |
| Thrombosis |
3.2% |
| Urine Ketone Body Present |
3.2% |
| Ventricular Tachycardia |
3.2% |
| Vomiting |
3.2% |
|
| Secondary |
| Drug Use For Unknown Indication |
35.5% |
| Product Used For Unknown Indication |
28.7% |
| Drug Exposure During Pregnancy |
6.8% |
| Anaesthesia |
5.8% |
| Prophylaxis |
4.6% |
| Epidural Anaesthesia |
2.7% |
| Maternal Exposure Timing Unspecified |
2.2% |
| Premedication |
2.0% |
| Hypertension |
1.8% |
| Antiphospholipid Syndrome |
1.6% |
| Poor Quality Sleep |
1.6% |
| Foetal Exposure During Pregnancy |
1.1% |
| Analgesic Therapy |
0.9% |
| Drug Detoxification |
0.8% |
| Anticoagulant Therapy |
0.7% |
| Bipolar Disorder |
0.7% |
| Colitis Ulcerative |
0.7% |
| Idiopathic Thrombocytopenic Purpura |
0.7% |
| Plasmapheresis |
0.7% |
| Arthritis |
0.5% |
|
| Therapeutic Agent Toxicity |
31.0% |
| Urinoma |
10.3% |
| Incorrect Route Of Drug Administration |
6.9% |
| Premature Rupture Of Membranes |
5.2% |
| Transverse Presentation |
5.2% |
| Twin Pregnancy |
5.2% |
| Drug Exposure During Pregnancy |
3.4% |
| Intestinal Stenosis |
3.4% |
| Intra-uterine Death |
3.4% |
| Loss Of Consciousness |
3.4% |
| Syncope |
3.4% |
| Unevaluable Event |
3.4% |
| Uterine Inversion |
3.4% |
| Drug Dependence |
1.7% |
| Exposure During Pregnancy |
1.7% |
| Foetal Exposure During Pregnancy |
1.7% |
| Gastrointestinal Cancer Metastatic |
1.7% |
| Mallory-weiss Syndrome |
1.7% |
| Metastases To Liver |
1.7% |
| Nephrolithiasis |
1.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.0% |
| Drug Use For Unknown Indication |
24.2% |
| Prophylaxis |
6.9% |
| Anaesthesia |
4.2% |
| Pain |
3.3% |
| Premedication |
3.1% |
| Acute Lymphocytic Leukaemia |
2.6% |
| Drug Exposure During Pregnancy |
2.4% |
| Prophylaxis Against Transplant Rejection |
2.4% |
| Multiple Myeloma |
1.9% |
| Nausea |
1.9% |
| Nuclear Magnetic Resonance Imaging |
1.7% |
| Myelitis Transverse |
1.5% |
| Neuralgia |
1.4% |
| Acute Myeloid Leukaemia |
1.3% |
| Pruritus |
1.2% |
| Rheumatoid Arthritis |
1.2% |
| Major Depression |
1.0% |
| Thrombosis Prophylaxis |
1.0% |
| Caesarean Section |
0.9% |
|
| Drug Exposure During Pregnancy |
13.2% |
| Premature Baby |
10.4% |
| Vomiting |
9.4% |
| Drug Withdrawal Syndrome |
7.5% |
| Therapeutic Agent Toxicity |
7.5% |
| Somnolence |
5.7% |
| Loss Of Consciousness |
4.7% |
| Vascular Resistance Systemic Decreased |
4.7% |
| White Blood Cell Count Decreased |
4.7% |
| Urinoma |
3.8% |
| Wheezing |
3.8% |
| Abdominal Pain |
2.8% |
| Pain |
2.8% |
| Sensory Loss |
2.8% |
| Shock |
2.8% |
| Syncope |
2.8% |
| Talipes |
2.8% |
| Thrombocytopenia |
2.8% |
| Venoocclusive Disease |
2.8% |
| Alanine Aminotransferase Increased |
1.9% |
|
